Disorders Due to Use of Unknown or Unspecified Psychoactive Substances (6C4G)

1. Introduction

Disorders due to the use of unknown or unspecified psychoactive substances represent a significant diagnostic challenge in contemporary clinical practice. This ICD-11 code (6C4G) was created specifically for situations in which healthcare professionals clearly identify a disorder related to substance use, but are unable to determine which specific substance is involved in the clinical presentation.

The clinical importance of this code lies in the growing complexity of the psychoactive substance use scenario. The constant emergence of new synthetic substances, the use of multiple drugs simultaneously, the adulteration of illicit substances, and emergency situations where the patient cannot provide reliable information make it essential to have an appropriate diagnostic category for these cases.

In public health practice, this code allows epidemiological surveillance systems to document cases where there is clear evidence of substance use disorder, even when specific identification is not immediately possible. This is particularly relevant in emergency services, detoxification units, and mental health settings where immediate intervention is necessary before complete laboratory identification.

Correct coding is critical for several reasons: it allows appropriate treatment of acute symptoms, facilitates planning of appropriate interventions, ensures accurate clinical documentation, enables epidemiological tracking of substance use patterns, and ensures adequate reimbursement for services provided. Once the specific substance is identified, the code should be updated to reflect the appropriate substance class, ensuring continuous diagnostic accuracy.

2. Correct ICD-11 Code

Code: 6C4G

Description: Disorders due to use of unknown or unspecified psychoactive substances

Parent category: Disorders due to substance use

Official definition: Disorders due to use of unknown or unspecified psychoactive substances are characterized by the pattern and consequences of psychoactive substance use, when the specific substance is unknown or unspecified. These categories may be used in clinical situations in which it is clear that the disorder is due to substance use, but the specific class of the substance is unknown. Once the substance in question is identified, the disorder should be recoded according to the appropriate substance class.

This code functions as a temporary or contingency category within the classification system. It acknowledges the clinical reality that it is not always possible to immediately identify all substances involved in a substance use disorder, but this should not prevent adequate documentation and initiation of appropriate treatment.

Code 6C4G has eight subcategories that allow better specification of the type of disorder presented, including single episode of harmful use, pattern of harmful use, dependence, intoxication, withdrawal, and psychotic disorders induced, among others. This structure allows detailed clinical documentation even in the absence of specific substance identification.

3. When to Use This Code

The code 6C4G should be used in specific clinical scenarios where there is clear evidence of substance use disorder, but identification of the substance is not possible or has not yet been completed.

Scenario 1: Unconscious patient in emergency A patient is brought to the emergency department in an altered state of consciousness, with abnormal vital signs and a history of possible substance use. Family members or witnesses confirm recent use of "something," but cannot specify what was used. Toxicological tests were collected but results will take hours or days. The patient presents symptoms compatible with psychoactive substance intoxication, but without specific characteristics that allow immediate identification.

Scenario 2: Use of adulterated or mixed substances Patient admits to using a substance acquired in an illicit context, described as a "synthetic drug" or "party pill," without knowledge of specific components. Presents symptoms of dependence and functional impairment, but the substance cannot be identified through standard tests. The composition may include multiple psychoactive substances that cannot be identified individually.

Scenario 3: Patient with amnesia or disorientation Individual presents clear symptoms of withdrawal or intoxication, but due to cognitive alterations, dissociative amnesia, or severe disorientation, cannot provide information about which substance was used. No witnesses are available and clinical findings are not specific enough to determine the substance class.

Scenario 4: Refusal to provide information Patient with clear clinical evidence of substance use disorder (physical, behavioral, and functional signs), but who refuses to provide information about which substance is being used. There may be legal issues, stigma, or other reasons for non-disclosure. Treatment needs to be initiated based on presented symptoms.

Scenario 5: New psychoactive substances that cannot be identified Patient reports use of a psychoactive substance newly available in the illicit market, not yet cataloged in toxicological databases. Presents a pattern of problematic use and negative consequences, but the substance does not fit into any known class available in the specific codes.

Scenario 6: Context of multiple substances without clear predominance Simultaneous use of several psychoactive substances where it is not possible to determine which is the primary substance responsible for the presented disorder, and the effects result from complex interactions that do not allow attribution to a specific class.

4. When NOT to Use This Code

The code 6C4G should not be used when there is sufficient information to identify the specific class of substance involved, even if the exact substance within that class is not known.

Do not use when:

If the patient or informants can clearly identify the class of substance (alcohol, cannabis, stimulants, opioids, etc.), even without knowing the specific formulation, the appropriate code for the substance class should be used. For example, if the patient reports problematic use of "some kind of sleeping pill" but does not know the name, this can still be coded as disorder due to use of sedatives, hypnotics, or anxiolytics.

When toxicological tests are readily available and can provide results in a timely manner for initial coding, one should wait for the results before using code 6C4G. This code is for situations where identification is not possible at the time coding is necessary.

If there is clear and unequivocal clinical evidence of a specific class of substance - such as characteristic odor of alcohol, pinpoint pupils typical of opioids, or specific benzodiazepine withdrawal symptoms - the specific code should be used even without laboratory confirmation.

Code 6C4G should not be used for primary mental disorders that are not a result of substance use. If there is doubt about whether the disorder is caused by substance or is an independent mental disorder, the primary mental disorder should be coded until the causal relationship with substance is established.

Do not use this code when the patient presents with recreational or experimental use of substances without development of a disorder. Code 6C4G is for established disorders, not for occasional use without consequences.

5. Step-by-Step Coding Process

Step 1: Assess diagnostic criteria

The first step is to confirm that a substance use disorder exists, regardless of which specific substance is involved. This requires identification of a problematic pattern of use with negative consequences.

Assess the presence of impaired control over use, increasing prioritization of substance use over other activities, continued use despite negative consequences, and evidence of tolerance or withdrawal. Document impairments in functional areas: work, relationships, physical health, social functioning.

Utilize adapted screening instruments when possible, focusing on behavioral patterns and consequences rather than specific substances. Structured clinical interview exploring use history, control attempts, experienced consequences, and current symptoms is essential.

Obtain collateral information from family members, caregivers, or previous medical records when the patient cannot provide reliable history. Physical examination may reveal signs of chronic substance use even without specific identification.

Step 2: Verify specifiers

After confirming the presence of substance use disorder, determine which specific subcategory of 6C4G is appropriate. This includes assessing whether it is a single episode of harmful use, pattern of harmful use, dependence, acute intoxication, withdrawal syndrome, or substance-induced mental disorder.

For dependence, verify presence of strong desire to use, control difficulties, withdrawal symptoms, tolerance, and neglect of alternative activities. For harmful use, document damage to physical or mental health caused by the use pattern.

Assess severity when applicable: mild, moderate, or severe, based on the number of criteria present and the extent of functional impairment. Document symptom duration and whether it is current episode or in remission.

Step 3: Differentiate from other codes

6C40 - Disorders due to use of alcohol: Use 6C40 when there is any evidence that alcohol is the primary substance, including characteristic odor, history of alcoholic beverage consumption, or compatible laboratory findings. Use 6C4G only when alcohol has been definitively excluded or there is insufficient information.

6C41 - Disorders due to use of cannabis: Use 6C41 when the patient reports use of marijuana, hashish, or cannabis products, or when there are characteristic clinical signs such as conjunctival hyperemia, increased appetite, and specific symptom pattern. Code 6C4G is reserved for when cannabis cannot be identified as the substance involved.

6C42 - Disorders due to use of synthetic cannabinoids: This code is for synthetic substances that mimic cannabis effects but have different chemical structure. Use 6C4G when it is not possible to determine whether the substance is natural cannabis or synthetic cannabinoid, or when the substance does not fit into any of these categories.

The key differentiation is that all specific codes (6C40, 6C41, 6C42, etc.) require identification of the substance class, while 6C4G is used specifically when such identification is not possible.

Step 4: Required documentation

Clearly document in the medical record the reasons why the specific substance cannot be identified. This may include: unconscious or uncooperative patient, contradictory information, adulterated or unidentifiable substance, awaiting test results, or multiple substances without clear predominance.

Record all observed symptoms and signs, history obtained from any source, identification attempts made (tests ordered, interviews conducted), and clinical justification for the substance use disorder diagnosis.

Include checklist of information: symptom onset date, reported use pattern (even without substance identification), observed consequences, previous treatment attempts, present comorbidities, and plan for later substance identification when possible.

Establish plan for reassessment and recoding as soon as the substance is identified. Document that code 6C4G is temporary and should be updated when additional information becomes available.

6. Complete Practical Example

Clinical Case:

A 28-year-old patient is brought to the emergency department by friends who found him in a state of extreme agitation, profuse diaphoresis, and paranoid behavior at a party. The companions report that the patient consumed "something someone offered," described as "colored pills," but no one knows exactly what it was.

On initial evaluation, the patient presents with tachycardia (120 bpm), hypertension (160/95 mmHg), temperature of 38.2°C, mydriatic pupils, generalized tremors, and significant psychomotor agitation. He is disoriented in time and space, with incoherent speech and paranoid ideation that "people are trying to harm him."

The patient is unable to provide a coherent history due to altered mental status. Friends deny knowledge of prior substance use, but mention that in recent weeks he was "different" and missing commitments. There is no known prior medical history of psychiatric disorders.

Physical examination reveals old venipuncture marks on upper extremities, suggesting possible prior intravenous use. There is no odor of alcohol. The patient presents with stereotyped movements and bruxism. Samples were collected for comprehensive toxicological screening, but results will take 48-72 hours.

During the first 24 hours of hospitalization, the patient evolves with fluctuating symptoms of agitation alternating with periods of drowsiness, maintains paranoid ideation, and reports visual hallucinations. Requires chemical restraint with benzodiazepines and antipsychotics. Gradually regains orientation, but remains amnestic for the event.

After stabilization, the patient reports that over the past three months he had been using "synthetic drugs" acquired over the internet, which changed composition frequently. He admits compulsive use, failed attempts to stop, neglect of work and relationships, but cannot specify which substances he was using, referring only to unidentifiable street names.

Step-by-Step Coding:

Criteria Analysis:

There is clear evidence of substance use disorder: pattern of use over the past three months, loss of control, compulsive use, neglect of important activities, continued negative consequences, and acute intoxication presentation with life-threatening risk.

The patient presents with symptoms compatible with intoxication by stimulant psychoactive substance, but the specific substance cannot be determined. It could be amphetamine, methamphetamine, synthetic cathinone, or other unidentifiable stimulant substances.

There is insufficient information to attribute the disorder to a specific class of substance. Toxicological tests have not yet returned and, even when they do, new synthetic substances may not be detected by standard panels.

Code Selected: 6C4G.10 - Episode of intoxication due to unknown or unspecified psychoactive substances

Additional Code: 6C4G.20 - Dependence on unknown or unspecified psychoactive substances (for the chronic pattern of use)

Complete Justification:

Code 6C4G is appropriate because: (1) there is unequivocal evidence of disorder related to psychoactive substance use; (2) the specific substance cannot be identified through history, physical examination, or tests available at the time; (3) the patient reports use of variable unspecifiable synthetic substances; (4) the symptoms are not specific enough to attribute to a single class of substance.

Subcode .10 captures the acute intoxication episode that prompted presentation to the emergency department. Subcode .20 documents the chronic pattern of dependence evidenced by the three-month history of compulsive use with negative consequences.

Complementary Codes:

6E61 - Acute and transient psychotic disorder (to document the psychotic symptoms present)
MB24.1 - Hyperthermia (for the temperature elevation)

Recoding Plan:

Documented in the medical record that when toxicological results return or when the patient is able to provide more specific information about the substances used, the code should be reassessed and updated to the appropriate class of substance, if identifiable.

7. Related Codes and Differentiation

Within the Same Category:

6C40 - Disorders due to use of alcohol

Use 6C40 when there is any indication that alcohol is the primary substance involved in the disorder. This includes patient or informant report of alcoholic beverage consumption, characteristic smell of alcohol, clinical signs such as alcoholic breath or typical facies, or laboratory results such as elevation of specific liver enzymes or detection of alcohol in blood.

The main difference from 6C4G is that 6C40 requires identification of alcohol as the substance, whereas 6C4G is used when there is no information about which substance is involved. If there is doubt between alcohol and another substance, but alcohol is a strong possibility, use 6C40.

6C41 - Disorders due to use of cannabis

Use 6C41 when the patient reports use of marijuana, hashish, cannabis oil, or other products derived from the Cannabis sativa plant. Suggestive clinical signs include conjunctival hyperemia, xerostomia, increased appetite, slowed reaction time, and characteristic pattern of cognitive symptoms.

Main difference vs. 6C4G: 6C41 requires identification of cannabis as the substance, whether by self-report, detection of THC on testing, or highly suggestive clinical presentation. Use 6C4G only when cannabis cannot be confirmed or when there is use of multiple substances without the ability to identify cannabis as primary.

6C42 - Disorders due to use of synthetic cannabinoids

This specific code is for synthetic substances that act on cannabinoid receptors but have a chemical structure different from natural cannabis. Examples include substances marketed as "incense" or "spices" with effects similar to but more intense than cannabis.

The difference from 6C4G is that 6C42 requires identification that the substance is a specific synthetic cannabinoid, usually through detailed patient report about the source and type of product, or laboratory identification. Use 6C4G when it is not possible to determine whether the substance is natural cannabis, synthetic, or an entirely different class.

Differential Diagnoses:

Primary psychotic disorders: May present with symptoms similar to intoxication or substance-induced psychosis. Differentiate through detailed history, timeline of symptoms (substance-induced psychosis typically has onset temporally related to use), and resolution with abstinence.

Delirium from other causes: May mimic substance intoxication. Investigate metabolic, infectious, neurological causes. The code 6C4G requires evidence of substance use as the cause.

Anxiety or panic disorders: Autonomic symptoms may be confused with intoxication or withdrawal. History of substance use and temporal context are fundamental for differentiation.

8. Differences with ICD-10

In ICD-10, the closest equivalent code would be F19 - Mental and behavioral disorders due to multiple drug use and use of other psychoactive substances. However, there was significant ambiguity about when to use this code versus codes for specific substances.

The main changes in ICD-11 include greater conceptual clarity about when to use the code for unspecified substances. ICD-11 explicitly states that this code is temporary and should be updated when the substance is identified, whereas ICD-10 did not provide such clear guidance.

The structure of subcategories in ICD-11 is more detailed, allowing specification of the type of disorder (intoxication, dependence, withdrawal, etc.) even without identifying the substance, which was not possible in such a granular manner in ICD-10.

Another important difference is that ICD-11 more clearly separates "unknown substances" (when one truly does not know which it is) from "multiple substances" (when it is known that there are several but one cannot be identified as primary), whereas ICD-10 grouped these situations together.

The practical impact is greater diagnostic precision even in situations of uncertainty, better epidemiological tracking of cases where the substance cannot be identified, and clearer guidance for professionals on documentation and subsequent recoding. ICD-11 also facilitates research on emerging patterns of use of new psychoactive substances.

9. Frequently Asked Questions

How is the diagnosis of disorder due to unknown substance made?

The diagnosis is based on identifying a problematic pattern of substance use with negative consequences, regardless of which specific substance is involved. The professional evaluates clinical history, present signs and symptoms, functional impairment, and evidence of loss of control over use. Even without identifying the substance, it is possible to diagnose the disorder through behavioral pattern and consequences. Toxicological tests are useful but not mandatory for diagnosis. The evaluation includes detailed clinical interview, physical examination, collateral information when possible, and use of validated screening instruments.

Is treatment available in public health systems?

Yes, treatments for substance use disorders are generally available in public health systems in various contexts. Treatment does not necessarily depend on specific substance identification, as many interventions are applicable regardless of the substance used. This includes supervised detoxification, management of acute symptoms, psychotherapy (especially cognitive-behavioral therapy and motivational interviewing), support groups, and longitudinal follow-up. Specific medications may be limited when the substance is unknown, but symptomatic treatment and psychosocial support can be offered. Specific availability varies according to local resources and organization of health services.

How long does treatment last?

Treatment duration varies significantly depending on disorder severity, individual response, and type of intervention. Acute detoxification generally takes days to weeks. Outpatient treatment for dependence typically lasts months to years, with varying intensity over time. Many experts recommend at least three months of active treatment for significant behavioral changes, but maintenance treatment and relapse prevention may continue for much longer periods. For severe disorders, long-term or permanent follow-up may be necessary. Later identification of the specific substance may influence adjustments to the therapeutic plan, but does not invalidate treatment already initiated.

Can this code be used in medical certificates?

Yes, code 6C4G can be used in official medical documentation, including certificates when appropriate. However, professionals should consider confidentiality and stigma issues. In some contexts, it may be preferable to use more general terminology such as "acute medical condition" or "disorder requiring treatment" in certificates intended for employers, while specific coding remains restricted to confidential clinical documentation. The decision should balance the need for accurate documentation with protection of patient privacy. Always obtain patient consent when possible before disclosing substance-related diagnoses in documents that will be shared with third parties.

How long should I wait before using this code instead of waiting for substance identification?

Use code 6C4G when coding is necessary and substance identification is not available at that moment. There is no mandatory waiting period. If you need to document the case for hospital admission, billing, or medical record, and the substance cannot be identified immediately, use 6C4G. If toxicological tests have been ordered but will take days to return, use 6C4G initially and update when results are available. The priority is not to delay appropriate documentation and treatment. The code was created precisely to allow accurate documentation even in the absence of immediate substance identification.

Can I use this code for patients using multiple substances simultaneously?

Yes, 6C4G can be used when there is use of multiple substances and it is not possible to identify a primary substance responsible for the disorder, or when the specific substances cannot be identified. However, if you can identify that multiple specific substances are involved (for example, alcohol and cocaine), it is preferable to use the specific codes for each substance instead of 6C4G. Use 6C4G specifically for situations where identification is not possible, not simply because there are multiple substances. ICD-11 allows coding of multiple substance use disorders when applicable.

What should I do if the substance is identified after I have already used code 6C4G?

When the substance is identified later - whether through test results, additional patient information, or other sources - you should update the code to the appropriate specific substance class. Document in the medical record the date of code change and the reason (for example: "code updated from 6C4G to 6C43 after toxicological results confirmed presence of cocaine"). This ensures continued diagnostic accuracy and allows proper tracking. Recoding does not invalidate previous treatment or documentation; it simply refines the diagnosis based on additional information. Keep a record that 6C4G was used initially to document the reason for the change.

Can this code be used for legal substances such as prescribed medications?

Yes, if there is a disorder related to use of prescribed medication but the specific medication cannot be identified, 6C4G can be used temporarily. However, it is generally possible to identify the medication class (sedatives, opioids, stimulants) through prescription records, packaging, or patient report, allowing use of a more specific code. Use 6C4G only when it is genuinely not possible to determine which substance class is involved. If you know it is a prescribed medication but not which one specifically, and can identify the pharmacological class, use the appropriate code for that class instead of 6C4G.

Final Note: This article provides clinical guidance based on the ICD-11 structure. Practical application should always consider the specific clinical context, local guidelines, and professional judgment. When in doubt about coding, consult substance use disorder specialists or medical coding services at your institution. Careful documentation and code updates when new information becomes available are essential for quality care and accurate medical records.

External References

This article was developed based on reliable scientific sources:

References verified on 2026-02-03

Disorders due to use of unknown or unspecified psychoactive substances

Partager